Skip to main content
Top
Published in: Diabetologia 2/2012

01-02-2012 | Article

Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy

Authors: H. R. Murphy, D. Elleri, J. M. Allen, J. Harris, D. Simmons, G. Rayman, R. C. Temple, A. M. Umpleby, D. B. Dunger, A. Haidar, M. Nodale, M. E. Wilinska, R. Hovorka

Published in: Diabetologia | Issue 2/2012

Login to get access

Abstract

Aims/hypothesis

Although maternal hyperglycaemia is associated with increased risk of adverse pregnancy outcome, the mechanisms of postprandial hyperglycaemia during pregnancy are poorly understood. We aimed to describe glucose turnover in pregnant women with type 1 diabetes, according to stage of gestation (early vs late gestation).

Methods

The rates of systemic glucose appearance (R a) and glucose disposal (R d) were measured in ten pregnant women with type 1 diabetes during early (12–16 weeks) and late (28–32 weeks) gestation. Women ate standardised meals—a starch-rich 80 g carbohydrate dinner and a sugar-rich 60 g carbohydrate breakfast—and fasted between meals and overnight. Stable-label isotope tracers ([6,6-2H2]glucose and [U-13 C]glucose) were used to determine R a, R d and glucose bioavailability. Closed-loop insulin delivery maintained stable glycaemic conditions.

Results

There were no changes in fasting R a (10 ± 2 vs 11 ± 2 μmol kg–1 min–1; p = 0.32) or fasting R d (11 ± 2 vs 11 ± 1 μmol kg–1 min–1; p = 0.77) in early vs late gestation. There was increased hepatic insulin resistance (381 ± 237 vs 540 ± 242 μmol kg–1 min–1 × pmol/l; p = 0.04) and decreased peripheral insulin sensitivity (0.09 ± 0.04 vs 0.05 ± 0.02 μmol kg–1 min–1 per pmol/l dinner, 0.11 ± 0.05 vs 0.07 ± 0.03 μmol kg–1 min–1 per pmol/l breakfast; p = 0.002) in late gestation. It also took longer for insulin levels to reach maximal concentrations (49 [37–55] vs 71 [52–108] min; p = 0.004) with significantly delayed glucose disposal (108 [87–125] vs 135 [110–158] min; p = 0.005) in late gestation.

Conclusions/interpretation

Postprandial glucose control is impaired by significantly slower glucose disposal in late gestation. Early prandial insulin dosing may help to accelerate glucose disposal and potentially ameliorate postprandial hyperglycaemia in late pregnancy.
Trial registration: ISRCTN 62568875
Funding: Diabetes UK Project Grant BDA 07/003551. H.R. Murphy is funded by a National Institute for Health Research (NIHR) research fellowship (PDF/08/01/036). Supported also by the Juvenile Diabetes Research Foundation (JDRF), Abbott Diabetes Care (Freestyle Navigator CGM and sensors free of charge), Medical Research Council Centre for Obesity and Related Metabolic Diseases and NIHR Cambridge Biomedical Research Centre.
Literature
1.
go back to reference Kalhan S, Rossi K, Gruca L, Burkett E, O’Brien A (1997) Glucose turnover and gluconeogenesis in human pregnancy. J Clin Invest 100:1775–1781PubMedCrossRef Kalhan S, Rossi K, Gruca L, Burkett E, O’Brien A (1997) Glucose turnover and gluconeogenesis in human pregnancy. J Clin Invest 100:1775–1781PubMedCrossRef
2.
go back to reference Murphy HR, Rayman G, Duffield K et al (2007) Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 30:2785–2791PubMedCrossRef Murphy HR, Rayman G, Duffield K et al (2007) Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 30:2785–2791PubMedCrossRef
3.
go back to reference Kalhan SC, D’Angelo LJ, Savin SM, Adam PA (1979) Glucose production in pregnant women at term gestation. Sources of glucose for human fetus. J Clin Invest 63:388–394PubMedCrossRef Kalhan SC, D’Angelo LJ, Savin SM, Adam PA (1979) Glucose production in pregnant women at term gestation. Sources of glucose for human fetus. J Clin Invest 63:388–394PubMedCrossRef
4.
go back to reference Baumann MU, Deborde S, Illsley NP (2002) Placental glucose transfer and fetal growth. Endocrine 19:13–22PubMedCrossRef Baumann MU, Deborde S, Illsley NP (2002) Placental glucose transfer and fetal growth. Endocrine 19:13–22PubMedCrossRef
5.
go back to reference Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A (2007) Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract 75:42–46PubMedCrossRef Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A (2007) Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract 75:42–46PubMedCrossRef
6.
go back to reference Kerssen A, de Valk HW, Visser GH (2007) Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care 30:1069–1074PubMedCrossRef Kerssen A, de Valk HW, Visser GH (2007) Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care 30:1069–1074PubMedCrossRef
7.
go back to reference Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK (1992) Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 15:1251–1257PubMedCrossRef Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK (1992) Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 15:1251–1257PubMedCrossRef
8.
go back to reference Macintosh MC, Fleming KM, Bailey JA et al (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333:177PubMedCrossRef Macintosh MC, Fleming KM, Bailey JA et al (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333:177PubMedCrossRef
9.
go back to reference Persson M, Norman M, Hanson U (2009) Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 32:2005–2009PubMedCrossRef Persson M, Norman M, Hanson U (2009) Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 32:2005–2009PubMedCrossRef
10.
go back to reference Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915PubMedCrossRef Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915PubMedCrossRef
11.
go back to reference Weiss PA, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH (2000) Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care 23:905–911PubMedCrossRef Weiss PA, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH (2000) Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care 23:905–911PubMedCrossRef
12.
go back to reference Clausen TD, Mathiesen ER, Hansen T et al (2008) High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 31:340–346PubMedCrossRef Clausen TD, Mathiesen ER, Hansen T et al (2008) High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 31:340–346PubMedCrossRef
13.
go back to reference Rijpert M, Evers IM, de Vroede MA, de Valk HW, Heijnen CJ, Visser GH (2009) Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: nationwide follow-up study in the Netherlands. Diabetes Care 32:2099–2104PubMedCrossRef Rijpert M, Evers IM, de Vroede MA, de Valk HW, Heijnen CJ, Visser GH (2009) Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: nationwide follow-up study in the Netherlands. Diabetes Care 32:2099–2104PubMedCrossRef
14.
go back to reference Priebe MG, Wachters-Hagedoorn RE, Heimweg JA et al (2008) An explorative study of in vivo digestive starch characteristics and postprandial glucose kinetics of wholemeal wheat bread. Eur J Nutr 47:417–423PubMedCrossRef Priebe MG, Wachters-Hagedoorn RE, Heimweg JA et al (2008) An explorative study of in vivo digestive starch characteristics and postprandial glucose kinetics of wholemeal wheat bread. Eur J Nutr 47:417–423PubMedCrossRef
15.
go back to reference Taylor R, Magnusson I, Rothman DL et al (1996) Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 97:126–132PubMedCrossRef Taylor R, Magnusson I, Rothman DL et al (1996) Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 97:126–132PubMedCrossRef
16.
go back to reference Basu R, Dalla Man C, Campioni M et al (2006) Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 55:2001–2014PubMedCrossRef Basu R, Dalla Man C, Campioni M et al (2006) Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 55:2001–2014PubMedCrossRef
17.
go back to reference Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA (1984) Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 74:985–991PubMedCrossRef Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA (1984) Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 74:985–991PubMedCrossRef
18.
go back to reference Pennant ME, Bluck LJ, Marcovecchio ML, Salgin B, Hovorka R, Dunger DB (2008) Insulin administration and rate of glucose appearance in people with type 1 diabetes. Diabetes Care 31:2183–2187PubMedCrossRef Pennant ME, Bluck LJ, Marcovecchio ML, Salgin B, Hovorka R, Dunger DB (2008) Insulin administration and rate of glucose appearance in people with type 1 diabetes. Diabetes Care 31:2183–2187PubMedCrossRef
19.
go back to reference Woerle HJ, Albrecht M, Linke R et al (2008) Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care 31:2325–2331PubMedCrossRef Woerle HJ, Albrecht M, Linke R et al (2008) Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide. Diabetes Care 31:2325–2331PubMedCrossRef
20.
go back to reference Chiloiro M, Darconza G, Piccioli E, de Carne M, Clemente C, Riezzo G (2001) Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol 36:538–543PubMedCrossRef Chiloiro M, Darconza G, Piccioli E, de Carne M, Clemente C, Riezzo G (2001) Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol 36:538–543PubMedCrossRef
21.
go back to reference National Institute for Health and Clinical Excellence. Diabetes in Pregnancy (2008) Management of diabetes and its complications in pregnancy from the pre-conception to the postnatal period. NICE Guideline 63. Available from www.nice.org.uk. Accessed 31 March 2011 National Institute for Health and Clinical Excellence. Diabetes in Pregnancy (2008) Management of diabetes and its complications in pregnancy from the pre-conception to the postnatal period. NICE Guideline 63. Available from www.​nice.​org.​uk. Accessed 31 March 2011
22.
go back to reference Murphy HR, Elleri D, Allen JM et al (2011) Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 34:406–411PubMedCrossRef Murphy HR, Elleri D, Allen JM et al (2011) Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 34:406–411PubMedCrossRef
23.
go back to reference Hovorka R (2011) Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 7:385–395PubMedCrossRef Hovorka R (2011) Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 7:385–395PubMedCrossRef
24.
go back to reference Hovorka R, Shojaee-Moradie F, Carroll PV et al (2002) Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol 282:E992–E1007 Hovorka R, Shojaee-Moradie F, Carroll PV et al (2002) Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol 282:E992–E1007
25.
go back to reference Shojaee-Moradie F, Jackson NC, Jones RH, Mallet AI, Hovorka R, Umpleby AM (1996) Quantitative measurement of 3-O-methyl-d-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo. J Mass Spectrom 31:961–966PubMedCrossRef Shojaee-Moradie F, Jackson NC, Jones RH, Mallet AI, Hovorka R, Umpleby AM (1996) Quantitative measurement of 3-O-methyl-d-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo. J Mass Spectrom 31:961–966PubMedCrossRef
26.
go back to reference Hovorka R, Jayatillake H, Rogatsky E, Tomuta V, Hovorka T, Stein DT (2007) Calculating glucose fluxes during meal tolerance test: a new computational approach. Am J Physiol 293:E610–E619 Hovorka R, Jayatillake H, Rogatsky E, Tomuta V, Hovorka T, Stein DT (2007) Calculating glucose fluxes during meal tolerance test: a new computational approach. Am J Physiol 293:E610–E619
27.
go back to reference Lunn DJ, Thomas A, Best N, Spiegelhalter D (2000) WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 10:325–337CrossRef Lunn DJ, Thomas A, Best N, Spiegelhalter D (2000) WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 10:325–337CrossRef
28.
go back to reference Mari A (1992) Estimation of the rate of appearance in the non-steady state with a two-compartment model. Am J Physiol 263:E400–E415PubMed Mari A (1992) Estimation of the rate of appearance in the non-steady state with a two-compartment model. Am J Physiol 263:E400–E415PubMed
29.
go back to reference Wilinska ME, Chassin LJ, Schaller HC, Schaupp L, Pieber TR, Hovorka R (2005) Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin. IEEE Trans Biomed Eng 52:3–12PubMedCrossRef Wilinska ME, Chassin LJ, Schaller HC, Schaupp L, Pieber TR, Hovorka R (2005) Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin. IEEE Trans Biomed Eng 52:3–12PubMedCrossRef
30.
go back to reference Catalano PM, Drago NM, Amini SB (1998) Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance. Diabetes Care 21:403–408PubMedCrossRef Catalano PM, Drago NM, Amini SB (1998) Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance. Diabetes Care 21:403–408PubMedCrossRef
31.
go back to reference Vora JP, Burch A, Peters JR, Owens DR (1992) Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 15:1484–1493PubMedCrossRef Vora JP, Burch A, Peters JR, Owens DR (1992) Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 15:1484–1493PubMedCrossRef
32.
go back to reference Gagnon-Auger M, du Souich P, Baillargeon JP et al (2010) Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study. Diabetes Care 33:2502–2507PubMedCrossRef Gagnon-Auger M, du Souich P, Baillargeon JP et al (2010) Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study. Diabetes Care 33:2502–2507PubMedCrossRef
33.
go back to reference Sandqvist M, Strindberg L, Schmelz M, Lonnroth P, Jansson PA (2011) Impaired delivery of insulin to adipose tissue and skeletal muscle in obese women with postprandial hyperglycemia. J Clin Endocrinol Metab 96:E1320–E1324PubMedCrossRef Sandqvist M, Strindberg L, Schmelz M, Lonnroth P, Jansson PA (2011) Impaired delivery of insulin to adipose tissue and skeletal muscle in obese women with postprandial hyperglycemia. J Clin Endocrinol Metab 96:E1320–E1324PubMedCrossRef
34.
go back to reference Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180:903–916PubMedCrossRef Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180:903–916PubMedCrossRef
35.
go back to reference Elleri D, Harris J, Kumareswaran K et al (2010) Glucose appearance of large slowly-absorbed evening meal containing complex carbohydrates (CHO) in type 1 diabetes (T1D). Diabetologia 53:S272 Elleri D, Harris J, Kumareswaran K et al (2010) Glucose appearance of large slowly-absorbed evening meal containing complex carbohydrates (CHO) in type 1 diabetes (T1D). Diabetologia 53:S272
36.
go back to reference Murphy HR, Rayman G, Lewis K et al (2008) Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337:a1680PubMedCrossRef Murphy HR, Rayman G, Lewis K et al (2008) Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337:a1680PubMedCrossRef
37.
go back to reference Luijf YM, van Bon AC, Hoekstra JB, Devries JH (2010) Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care 33:2152–2155PubMedCrossRef Luijf YM, van Bon AC, Hoekstra JB, Devries JH (2010) Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care 33:2152–2155PubMedCrossRef
38.
39.
go back to reference Chen MJ, Jovanovic A, Taylor R (2010) Utilizing the second-meal effect in type 2 diabetes: practical use of a soya–yogurt snack. Diabetes Care 33:2552–2554PubMedCrossRef Chen MJ, Jovanovic A, Taylor R (2010) Utilizing the second-meal effect in type 2 diabetes: practical use of a soya–yogurt snack. Diabetes Care 33:2552–2554PubMedCrossRef
40.
go back to reference Basu R, Di Camillo B, Toffolo G et al (2003) Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol 284:E55–E69 Basu R, Di Camillo B, Toffolo G et al (2003) Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol 284:E55–E69
41.
go back to reference Haidar A, Elleri D, Allen JM et al (2010) Triple tracer (TT) and double tracer (DT) techniques are reliable methods to estimate glucose appearance in type 1 diabetes. Diabetologia 53:S271 Haidar A, Elleri D, Allen JM et al (2010) Triple tracer (TT) and double tracer (DT) techniques are reliable methods to estimate glucose appearance in type 1 diabetes. Diabetologia 53:S271
42.
go back to reference Ferrannini E, Bjorkman O, Reichard GA Jr et al (1985) The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes 34:580–588PubMedCrossRef Ferrannini E, Bjorkman O, Reichard GA Jr et al (1985) The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes 34:580–588PubMedCrossRef
43.
go back to reference Mari A, Wahren J, DeFronzo RA, Ferrannini E (1994) Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metab Clin Exp 43:1419–1425PubMedCrossRef Mari A, Wahren J, DeFronzo RA, Ferrannini E (1994) Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metab Clin Exp 43:1419–1425PubMedCrossRef
44.
go back to reference Livesey G, Wilson PD, Dainty JR et al (1998) Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. Am J Physiol 275:E717–E728PubMed Livesey G, Wilson PD, Dainty JR et al (1998) Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. Am J Physiol 275:E717–E728PubMed
45.
go back to reference Murphy HR, Elleri D, Allen J et al (2011) Changes in glucose turnover during pregnancy in women with type 1 diabetes. Diabetes 60:A54 Murphy HR, Elleri D, Allen J et al (2011) Changes in glucose turnover during pregnancy in women with type 1 diabetes. Diabetes 60:A54
Metadata
Title
Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy
Authors
H. R. Murphy
D. Elleri
J. M. Allen
J. Harris
D. Simmons
G. Rayman
R. C. Temple
A. M. Umpleby
D. B. Dunger
A. Haidar
M. Nodale
M. E. Wilinska
R. Hovorka
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2363-6

Other articles of this Issue 2/2012

Diabetologia 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.